← Eichor
Study identifier: NCT07215130 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas

Condition: Ovarian Endometrioma · Endometriosis  ·  Sponsor: Kanazawa University

PhaseN/A
Planned participants10
Who can joinFemale, 20 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to evaluate the feasibility and tissue selectivity of a novel surgical technology, the Cavitron Ultrasonic Surgical Aspirator (CUSA) Clarity, in the management of ovarian endometriomas. Ovarian endometriomas are cysts caused by endometriosis that can damage ovarian reserve when treated by conventional surgery. In this study, ovarian cyst wall specimens are examined ex vivo using different Tissue Select settings of the CUSA device. Histopathological analyses are performed to determine whether endometriotic epithelium can be selectively removed while preserving normal ovarian tissue. The findings may contribute to developing fertility-preserving surgical approaches for women with endometriomas.

This description comes directly from the study's public registry record.

Talk to the study team

Tatsuhito Kanda, MD, PhD  ·  +81-76-265-2425  ·  tkanda@staff.kanazawa-u.ac.jp

Takashi Iizuka, MD, PhD  ·  +81-76-265-2425  ·  zukatti@staff.kanazawa-u.ac.jp

Always discuss trial participation with your own doctor first.

Locations (1)

Kanazawa University HospitalKanazawa, Ishikawa-ken, JapanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07215130